Oligonucleotide conjugates for therapeutic applications.
about
Therapeutic Oligonucleotides Targeting Liver Disease: TTR AmyloidosisAntisense mediated splicing modulation for inherited metabolic diseases: challenges for deliverymiRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agentsPleiotropic action of CpG-ODN on endothelium and macrophages attenuates angiogenesis through distinct pathways.The delivery of therapeutic oligonucleotidesCarrier-free Gene Silencing by Amphiphilic Nucleic Acid Conjugates in Differentiated Intestinal Cells.LC-MS of oligonucleotides: applications in biomedical research.Vectors for the delivery of radiopharmaceuticals in cancer therapeutics.Therapeutic oligonucleotides with polyethylene glycol modifications.Bioconjugates for targeted delivery of therapeutic oligonucleotides.Polyamine-oligonucleotide conjugates: a promising direction for nucleic acid tools and therapeutics.Injection site reactions after subcutaneous oligonucleotide therapyConcise postsynthetic preparation of oligonucleotide-oligopeptide conjugates through facile disulfide bond formation.Chemically defined polyethylene glycol siRNA conjugates with enhanced gene silencing effect.Engineered Hydrogels for Local and Sustained Delivery of RNA-Interference Therapies.Locked Nucleic Acid Gapmers and Conjugates Potently Silence ADAM33, an Asthma-Associated Metalloprotease with Nuclear-Localized mRNADendrimer Conjugates for Light-activated Delivery of Antisense Oligonucleotides.Oligonucleotides conjugated with short chemically defined polyethylene glycol chains are efficient antisense agentsRNAi-Mediated Knockdown of Protein Expression.Using Genome Sequence to Enable the Design of Medicines and Chemical Probes.In Vivo RNAi Efficacy of Palmitic Acid-Conjugated Dicer-Substrate siRNA in a Subcutaneous Tumor Mouse Model.Analysis and Purification of Synthetic Nucleic Acids Using HPLC.A General Overview on Non-coding RNA-Based Diagnostic and Therapeutic Approaches for Liver Diseases
P2860
Q26782089-3915B88F-B298-4DF7-B40B-A34F67F74793Q26830637-0CA3311F-00A4-4258-B68B-13452BC093E7Q27023295-9D444934-D74D-418F-9D9D-197B28FDAE5FQ37202398-8957D7CA-6168-44E6-BAE7-40FFF94AA07BQ37210936-2E4159CE-62D4-4461-B05F-F5079A2131B5Q37325084-DBF2A725-3AC7-4459-8175-FC7255D11ADDQ38232125-578A6B2A-C63B-4B5C-9DD5-DEBBB50131D9Q38261959-1D53E3C6-2260-495F-8A33-898C57EDD70BQ38296021-70EB0F08-AA34-4ED3-BD6E-51D0A760431DQ38301011-C61A2A44-F358-4EE6-9936-9E614C0837B5Q38596143-CCD60531-D261-400A-B021-280DA37C3E97Q38803235-4C25045C-51F7-4AD3-966F-207CC90710D9Q38834667-867A1879-D839-4142-8FCA-1F4E8B6914A2Q38868870-09848937-86CC-48F2-BD36-E6CF9B5AE40FQ39038930-B07E8510-2E58-49BE-8D1B-31A1EA9674B3Q41520047-6637A89A-05D6-4118-95B7-D53FA82E97F3Q41573307-08BB2BFA-BF4B-4416-9280-BBD2C0493DC5Q42265947-00A1560F-E42B-43D0-BB62-653917EFF2C2Q47684243-610873AA-8CA9-4CF9-B27B-60B9DA283FBCQ48263612-FD2B689D-D48E-41FE-B9A9-CA0139C9B1A1Q50234594-32C7609A-1466-4437-9D87-9EA2725A4E09Q53359934-09193426-42F6-4CAB-826F-BCB070FF7848Q57169221-C2236AE3-3470-4881-AD0C-ABC3244FE019
P2860
Oligonucleotide conjugates for therapeutic applications.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Oligonucleotide conjugates for therapeutic applications.
@en
type
label
Oligonucleotide conjugates for therapeutic applications.
@en
prefLabel
Oligonucleotide conjugates for therapeutic applications.
@en
P2860
P356
P1433
P1476
Oligonucleotide conjugates for therapeutic applications
@en
P2093
Johannes Winkler
P2860
P304
P356
10.4155/TDE.13.47
P577
2013-07-01T00:00:00Z